BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND LDH AND Prognosis
79 results:

  • 1. Evaluation of a novel model incorporating serological indicators into the conventional TNM staging system for nasopharyngeal carcinoma.
    Ding C; Dai DY; Luo ZK; Wang GY; Dong Z; Qin GJ; Du XJ; Ma J
    Oral Oncol; 2024 Apr; 151():106725. PubMed ID: 38430711
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan head neck Society registry database.
    Lu HJ; Hsieh MC; Wang HM; Hsieh JC; Yen CJ; Wu SY; Huang HC; Wang HC; Chu PY; Chen TH; Chien CY; Huang TL; Chang YF; Hua CH; Lien MY; Chen JP; Lu WC; Lin JC; Wang CC; Liu YC; Yang MH; Lou PJ
    Head Neck; 2024 May; 46(5):1063-1073. PubMed ID: 38385970
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
    Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
    Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients.
    Wu YX; Tian BY; Ou XY; Wu M; Huang Q; Han RK; He X; Chen SL
    Cancer Immunol Immunother; 2024 Jan; 73(1):14. PubMed ID: 38236288
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study.
    Wang F; Zhou L; Zhang LJ; Xie CB; Liao ZW; Lin XD; Wen YF
    Radiother Oncol; 2024 Feb; 191():110081. PubMed ID: 38185256
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma.
    Cao K; Zhu J; Lu M; Zhang J; Yang Y; Ling X; Zhang L; Qi C; Wei S; Zhang Y; Ma J
    EBioMedicine; 2024 Jan; 99():104920. PubMed ID: 38101299
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors.
    Kang D; Liu S; Yuan X; Liu S; Zhang Z; He Z; Yin X; Mao H
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18215-18240. PubMed ID: 38078963
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic nutritional index and serum lactate dehydrogenase predict the prognosis of nasopharyngeal carcinoma patients who received intensity-modulated radiation therapy.
    Zhang C; Zhan Z; Fang Y; Ruan Y; Lin M; Dai Z; Zhang Y; Yang S; Xiao S; Chen B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17795-17805. PubMed ID: 37934254
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.
    Liang L; Li Y; Hong Y; Ji T; Chen H; Lin Z
    Curr Oncol; 2023 Jul; 30(8):7189-7202. PubMed ID: 37623002
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study.
    Chen K; Xu J; Wang W; Jiang R; Zhang H; Wang X; Cao J; Fang M
    Cancer Med; 2023 May; 12(10):11363-11374. PubMed ID: 37081723
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of serum α-HBDH levels in patients with lung cancer.
    Yuan ZM; Wang LH; Chen C
    World J Surg Oncol; 2023 Mar; 21(1):78. PubMed ID: 36872314
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and head & neck cancer- A Systematic Review and Meta-analysis.
    S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
    Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
    Di M; Miao J; Pan Q; Wu Z; Chen B; Wang M; Zhao J; Huang H; Bai J; Wang Q; Tang Y; Li Y; He J; Xiang T; Weng D; Wang L; Xia J; Zhao C
    J Exp Clin Cancer Res; 2022 Nov; 41(1):328. PubMed ID: 36411454
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
    Lo WL; Huang WH; Yeh CF
    In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical characteristics and outcomes of newly diagnosed patients with HIV-associated aggressive B-cell NHL in China.
    Wang C; Liu J; Lei H; Li Y; Wu J; Guo B; Hu R; Liu T; Wu J; Ding Y; Hu C; Liang S; Xiao C; Liang X; Huang D; Yang T; Zhang W; Yang Z; Li J; Nan Y; Li Q; Xiang Y; Li Z; Wu Y; Liu Y
    J Cell Mol Med; 2022 Oct; 26(19):5067-5077. PubMed ID: 36056692
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma.
    Li Y; Wang K; Zhao E; Li B; Li S; Dong X; Yuan L; Yang H
    Pathol Oncol Res; 2022; 28():1610245. PubMed ID: 35721326
    [No Abstract]    [Full Text] [Related]  

  • 18. Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer.
    Li RY; Zheng ZY; Li ZM; Heng JH; Zheng YQ; Deng DX; Xu XE; Liao LD; Lin W; Xu HY; Huang HC; Li EM; Xu LY
    Chem Biol Interact; 2022 Jul; 361():109967. PubMed ID: 35525317
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Imaging and Laboratory Workup for Melanoma.
    Kaleem A; Patel N; Chandra SR; Vijayaraghavan RL
    Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):235-250. PubMed ID: 35428504
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical features of diffuse large B-cell lymphoma in head and neck].
    Xie M; Zhang Q; Guo R; Ma S; Liu X; Chen Y; Shao N; Liu H; Luo H; Ren X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jan; 36(1):1-7. PubMed ID: 34979610
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 4.